1747-75-7 Usage
General Description
4-CYCLOHEXENYLBENZENAMINE, also known as 4-phenylcyclohexylamine, is an organic compound with the chemical formula C13H17N. It is a cyclohexylamine derivative with a benzene ring attached to the carbon in the cyclohexene ring. 4-CYCLOHEXENYLBENZENAMINE is commonly used as a precursor in the synthesis of various pharmaceuticals and organic compounds. It has also been studied for its potential use in the treatment of a range of conditions including depression, anxiety, and other neurological disorders. Additionally, it is used in research and development for the synthesis of new compounds and as a building block in the pharmaceutical industry.
Check Digit Verification of cas no
The CAS Registry Mumber 1747-75-7 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,7,4 and 7 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1747-75:
(6*1)+(5*7)+(4*4)+(3*7)+(2*7)+(1*5)=97
97 % 10 = 7
So 1747-75-7 is a valid CAS Registry Number.
InChI:InChI=1/C12H15N/c13-12-8-6-11(7-9-12)10-4-2-1-3-5-10/h4,6-9H,1-3,5,13H2
1747-75-7Relevant articles and documents
GLUCAGON ANTAGONISTS/INVERSE AGONISTS
-
Page/Page column 162, (2010/02/14)
A novel class of compounds, which act to antagonize the action of the glucagon hormone on the glucagon receptor. Owing to their antagonizing effect of the glucagon receptor the compounds may be suitable for the treatment and/or prevention of any glucagon-
Glucagon antagonists/inverse agonists
-
, (2008/06/13)
Novel compounds, which act to antagonize the action of the glucagon hormone on the glucagon receptor. Owing to their antagonizing effect of the glucagon receptor the compounds may be suitable for the treatment and/or prevention of any diseases and disorde
Glucagon antagonists/inverse agonists
-
, (2008/06/13)
A novel class of compounds, which act to antagonize the action of the glucagon hormone on the glucagon receptor. Owing to their antagonizing effect of the glucagon receptor the compounds may be suitable for the treatment and/or prevention of any diseases